Author

Annemieke De Ridder

Observed names: A De Ridder, A. De Ridder, DE RIDDER, Annemieke

Observed institution: University of Antwerp

OpenAlex ID: A5111521852

Healthcare Use, Social Burden and Costs of Children With and Without ADHD in Flanders, Belgium

2006 · Annemieke De Ridder, Diana De Graeve · Clinical Drug Investigation · 53

Comparing the Cost Effectiveness of Risperidone and Olanzapine in the Treatment of Schizophrenia Using the Net-Benefit Regression Approach

2009 · Annemieke De Ridder, Diana De Graeve · PharmacoEconomics · 16

Cost Effectiveness of Drug-Eluting Stents In Belgian Practice

2009 · Mattias Neyt, Chris De Laet, et al. · PharmacoEconomics · 15

Drug eluting stents in Belgium: health technology assessment

2007 · Mattias Neyt, Hans Van Brabandt, et al. · 11

(Un)desirable effects of output funding for Flemish universities

2011 · B. Cantillon, A. De Ridder, et al. · Economics of Education Review · 10

The impact of assessment tasks on subsequent examination performance

2013 · Frank Van Gaal, Annemieke De Ridder · Active Learning in Higher Education · 9

Can we account for selection bias? A comparison between bare metal and drug-eluting stents

2011 · Annemieke De Ridder, Diana De Graeve · Value in Health · 9

PDF

Order bias in estimates of willingness to pay for drugs to treat attention-deficit/hyperactivity disorder

2005 · Annemieke De Ridder, Diana De Graeve · The European Journal of Health Economics · 5

Economic analysis of the use of drug-eluting stents from the perspective of Belgian health care.

2007 · J. Mahieu, A. De Ridder, et al. · Acta Cardiologica · 4

Drug Elutings Stents in Belgium

2007 · Mattias Neyt, Hans Van Brabandt, et al. · 2

PDF

Drug Eluting Stents en Belgique

2007 · Mattias Neyt, Hans Van Brabandt, et al. · 1

PDF

Drug Eluting Stents in België

2007 · Mattias Neyt, Hans Van Brabandt, et al. · 1

PDF

Portfolio zakelijke communicatie : casus activerende werkvormen

2011 · Margo Abrath, Tine Lambreghts, et al. · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)

Essays on economic evaluation in health economics - Bridging the gap with health econometrics - applications in ADHD, schizophrenia and stents

2010 · Annemieke De Ridder

Pmh26 Using the Net-benefit Regression Approach to Compare the Cost-effectiveness of Haloperidol, Olanzapine and Risperidone in the Treatment of Schizophrenia

2007 · A De Ridder, D De Graeve · Value in Health

PDF

Comparing the Cost-Effectiveness of Haloperidol, Olanzapine and Risperidone in the Treatment of Schizophrenia Using the Net-Benefit Regression Approach

2007 · Annemieke De Ridder, Diana De Graeve · SSRN Electronic Journal

Economic evaluations of diagnosis and treatment programmes for tuberculosis in developing countries: a review

2005 · Diana De Graeve, Annemieke De Ridder, et al. · Acta Academica Critical views on society culture and politics

PDF

Mh4 Children With Adhd (attention-deficit/hyperactivity Disorder): Health Care Use and Social Burden on the Family

2003 · A De Ridder, D De Graeve, et al. · Value in Health

PDF

Order bias in estimates of willingness to pay for drugs to treat attention-deficit/hyperactivity disorder: a contingent valuation study among students

2002 · Annemieke De Ridder, Diana De Graeve · RePEc: Research Papers in Economics

De dynamiek van samenwerking: theorieën en modellen

2002 · A.M.A. van Deemen, A.J.A. Godfroij, et al.

Works count: 22

Citation count: 136

H-index: 7

I10-index: 5